Chemistry, manufacturing, and controls strategies for antibody-targeted lipid nanoparticles
-
Antibody-targeted lipid nanoparticles (Ab-LNPs) represent a highly promising delivery platform for precision therapy, enabling efficient in vivo targeted delivery of nucleic acid drugs such as mRNA, DNA and siRNA. Currently, the two primary strategies ...
MoreAntibody-targeted lipid nanoparticles (Ab-LNPs) represent a highly promising delivery platform for precision therapy, enabling efficient in vivo targeted delivery of nucleic acid drugs such as mRNA, DNA and siRNA. Currently, the two primary strategies for antibody functionalization of LNPs are the post-insertion method and direct surface conjugation. This review outlines the key chemistry, manufacturing, and controls challenges associated with scaling up of Ab-LNP production, with a focus on antibody modification strategies, process scale-up challenges, and quality control considerations. It aims to provide practical guidance for translating Ab-LNP technology from laboratory research to scalable manufacturing.
Less -
Ri Huang, ... Congcong Xu
-
DOI: https://doi.org/10.70401/bmeh.2026.0022 - April 01, 2026
-
This article belongs to the Special Issue Engineering RNA Delivery Technologies for Vaccine and Therapeutic Development

